Evidence map›Paper›PMID 32419766›Full record

ArticleAnnals of epidemiology2020

Assessing differential impacts of COVID-19 on black communities.

Gregorio A Millett, Austin T Jones, David Benkeser, Stefan Baral, Laina Mercer, Chris Beyrer, Brian Honermann, Elise Lankiewicz, Leandro Mena, Jeffrey S Crowley and 2 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Annals of epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 635 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
635citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04505774 phase4completednot on this map

A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults With COVID-19

TypeinterventionalSponsorMatthew Neal MDRan2020 to 2024Enrolled3,591ConditionsCovid19Armstheraputic heparin, prophylactic heparin, P2Y12, Crizanlizumab Injection, SGLT2 inhibitor
NCT05270694 nacompletednot on this mapstarted 2022, after this paper: background citation

Understanding Factors Influencing COVID-19 Testing and Vaccination in Immigrant, Low-income and Unhoused Populations, and Testing Targeted Interventions [3U54GM115516=04S2 RADx-UP]

TypeinterventionalSponsorKathleen FairfieldRan2022 to 2023Enrolled102ConditionsCOVID-19ArmsPublic Health Intervention Package
3 · Its place in the literature

Who cites it

635 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Improving COVID-19 Vaccine Uptake among Black Populations: A Systematic Review of Strategies.International journal of environmental research and public health · 2022
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Changes in caregiver mental health and pediatric asthma control during COVID-19.The Journal of asthma : official journal of the Association for the Care of Asthma · 2023
    Trial
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

575 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gregorio A MillettPublic Policy Office, amfAR, Foundation for AIDS Research, Washington, DC.
Austin T JonesPublic Policy Office, amfAR, Foundation for AIDS Research, Washington, DC.
David BenkeserDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA.
Stefan BaralDepartment of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.
Laina MercerCenter for Vaccine Innovation and Access, PATH, Seattle, WA.
Chris BeyrerDepartment of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.
Brian HonermannPublic Policy Office, amfAR, Foundation for AIDS Research, Washington, DC.
Elise LankiewiczPublic Policy Office, amfAR, Foundation for AIDS Research, Washington, DC.
Leandro MenaJohn D. Bower School of Population Health, University of Mississippi Medical Center, Jackson, MS.
Jeffrey S CrowleyO'Neill Institute for National and Global Health Law, Georgetown University, Washington, DC.
Jennifer SherwoodPublic Policy Office, amfAR, Foundation for AIDS Research, Washington, DC.
Patrick S SullivanDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Given incomplete data reporting by race, we used data on COVID-19 cases and deaths in U.S. counties to describe racial disparities in COVID-19 disease and death and associated determinants. Methods: Using publicly available data (accessed April 13, 2020), predictors of COVID-19 cases and deaths were compared between disproportionately (≥13%) black and all other (<13% black) counties. Rate ratios were calculated, and population attributable fractions were estimated using COVID-19 cases and deaths via zero-inflated negative binomial regression model. National maps with county-level data and an interactive scatterplot of COVID-19 cases were generated. Results: Nearly 90% of disproportionately black counties (656/677) reported a case and 49% (330/677) reported a death versus 81% (1987/2465) and 28% (684/2465), respectively, for all other counties. Counties with higher proportions of black people have higher prevalence of comorbidities and greater air pollution. Counties with higher proportions of black residents had more COVID-19 diagnoses (Rate Ratio (RR): 1.24, 95% confidence interval: 1.17-1.33) and deaths (RR: 1.18, 95% confidence interval: 1.00-1.40), after adjusting for county-level characteristics such as age, poverty, comorbidities, and epidemic duration. COVID-19 deaths were higher in disproportionally black rural and small metro counties. The population attributable fraction of COVID-19 diagnosis due to lack of health insurance was 3.3% for counties with less than 13% black residents and 4.2% for counties with greater than or equal to 13% black residents. Conclusions: Nearly 20% of U.S. counties are disproportionately black, and they accounted for 52% of COVID-19 diagnoses and 58% of COVID-19 deaths nationally. County-level comparisons can both inform COVID-19 responses and identify epidemic hot spots. Social conditions, structural racism, and other factors elevate risk for COVID-19 diagnoses and deaths in black communities.

Indexed as

CoronavirusHealth Status DisparitiesBetacoronavirusBlack or African AmericanCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralRural PopulationSARS-CoV-2African-AmericanBlackCOVID-19DisparityRace

Identifiers

PMID32419766
PMCPMC7224670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.